Publications by the researcher in collaboration with ANGEL LUIS ORTEGA VALERO (26)

2016

  1. Glutathione in metastases: From mechanisms to clinical applications

    Critical Reviews in Clinical Laboratory Sciences, Vol. 53, Núm. 4, pp. 253-267

  2. Role of natural stilbenes in the prevention of cancer

    Oxidative Medicine and Cellular Longevity, Vol. 2016

2015

  1. Topical treatment with pterostilbene, a natural phytoalexin, effectively protects hairless mice against UVB radiation-induced skin damage and carcinogenesis

    Free Radical Biology and Medicine, Vol. 85, pp. 1-11

2013

  1. Pterostilbene: Biomedical applications

    Critical Reviews in Clinical Laboratory Sciences, Vol. 50, Núm. 3, pp. 65-78

2012

  1. Glutathione and Bcl-2 targeting facilitates elimination by chemoradiotherapy of human A375 melanoma xenografts overexpressing bcl-xl, bcl-2, and mcl-1

    Journal of Translational Medicine, Vol. 10, Núm. 1

  2. Pterostilbene-Induced Tumor Cytotoxicity: A Lysosomal Membrane Permeabilization-Dependent Mechanism

    PLoS ONE, Vol. 7, Núm. 9

2011

  1. Glutathione in cancer cell death

    Cancers, Vol. 3, Núm. 1, pp. 1285-1310

  2. Natural polyphenols in cancer therapy

    Critical Reviews in Clinical Laboratory Sciences, Vol. 48, Núm. 5-6, pp. 197-216

2010

  1. Oxidative and nitrosative stress in the metastatic microenvironment

    Cancers, Vol. 2, Núm. 2, pp. 274-304

2009

  1. Oxidative stress in environmental-induced carcinogenesis

    Mutation Research - Genetic Toxicology and Environmental Mutagenesis, Vol. 674, Núm. 1-2, pp. 36-44

2008

  1. Glutathione, Sulfur Amino Acids, and Cancer

    Glutathione and Sulfur Amino Acids in Human Health and Disease (John Wiley & Sons, Inc.), pp. 471-500

  2. Natural polyphenols facilitate elimination of HT-29 colorectal cancer xenografts by chemoradiotherapy: A Bcl-2- and superoxide dismutase 2-dependent mechanism

    Molecular Cancer Therapeutics, Vol. 7, Núm. 10, pp. 3330-3342

  3. Tumoricidal activity of endothelium-derived NO and the survival of metastatic cells with high GSH and Bcl-2 levels

    Nitric Oxide - Biology and Chemistry, Vol. 19, Núm. 2, pp. 107-114

2007

  1. Bcl-2 and glutathione depletion sensitizes B16 melanoma to combination therapy and eliminates metastatic disease

    Clinical Cancer Research, Vol. 13, Núm. 9, pp. 2658-2666

  2. Nitric oxide mediates natural polyphenol-induced Bcl-2 down-regulation and activation of cell death in metastatic B16 melanoma

    Journal of Biological Chemistry, Vol. 282, Núm. 5, pp. 2880-2890

2006

  1. Bcl-2 and Mn-SOD antisense oligodeoxynucleotides and a glutamine-enriched diet facilitate elimination of highly resistant B16 melanoma cells by tumor necrosis factor-α and chemotherapy

    Journal of Biological Chemistry, Vol. 281, Núm. 1, pp. 69-79

  2. Glutathione in cancer biology and therapy

    Critical Reviews in Clinical Laboratory Sciences, Vol. 43, Núm. 2, pp. 143-181

2005

  1. Acceleration of glutathione efflux and inhibition of γ- glutamyltranspeptidase sensitize metastatic B16 melanoma cells to endothelium-induced cytotoxicity

    Journal of Biological Chemistry, Vol. 280, Núm. 8, pp. 6950-6959

  2. Association between pterostilbene and quercetin inhibits metastatic activity of B16 melanoma

    Neoplasia, Vol. 7, Núm. 1, pp. 37-47

2004

  1. A Role for the 2-Oxoglutarate Carrier in Glutathione Transport into Hepatocyte Mitochondria? [3] (multiple letters)

    Hepatology